MAP1LC3A and ovarian carcinoma: These results are partly consistent with those of previous reports showing that ZnO NP treatment increased autophagic biomarkers, such as LC3 expression and LC3-FITC antibody-positive cells in ovarian cancer cells and macrophages [39,40].